| 1 | conservative | 3,544 |
| 2 | cognitive-behavioral | 1,258 |
| 3 | non-surgical | 739 |
| 4 | expectant | 692 |
| 5 | nonsurgical | 620 |
| 6 | nonoperative | 522 |
| 7 | endodontic | 472 |
| 8 | cognitive-behavioural | 415 |
| 9 | psychodynamic | 401 |
| 10 | contingency | 393 |
| 11 | syndromic | 285 |
| 12 | multimodality | 235 |
| 13 | non-operative | 170 |
| 14 | placebo/no | 140 |
| 15 | psychoanalytic | 97 |
| 16 | atenolol-based | 76 |
| 17 | risk-adapted | 68 |
| 18 | rate-control | 66 |
| 19 | combined-modality | 57 |
| 20 | rhythm-control | 54 |
| 21 | nt-probnp-guided | 49 |
| 22 | single-visit | 40 |
| 23 | dual-combination | 36 |
| 24 | eclectic | 32 |
| 25 | multi-modality | 32 |
| 26 | pharmacoinvasive | 32 |
| 27 | solution-focused | 30 |
| 28 | depression-specific | 29 |
| 29 | endourologic | 29 |
| 30 | nonbeneficial | 29 |
| 31 | guidelines-based | 25 |
| 32 | gut-directed | 25 |
| 33 | medicamentous | 25 |
| 34 | trimodality | 25 |
| 35 | next-step | 24 |
| 36 | supportive-expressive | 24 |
| 37 | 2-visit | 23 |
| 38 | 3-wall | 23 |
| 39 | single-modality | 23 |
| 40 | one-visit | 22 |
| 41 | two-visit | 21 |
| 42 | mentalization-based | 20 |
| 43 | non-extraction | 19 |
| 44 | present-centered | 19 |
| 45 | orthograde | 17 |
| 46 | t2t | 16 |
| 47 | breast-conservation | 15 |
| 48 | medication-assisted | 15 |
| 49 | multiple-visit | 15 |
| 50 | trimodal | 15 |
| 51 | two-stent | 14 |
| 52 | coseasonal | 13 |
| 53 | mcri | 13 |
| 54 | substance-abuse | 13 |
| 55 | mutilating | 12 |
| 56 | therapist-administered | 12 |
| 57 | cbt/met | 11 |
| 58 | insulin-providing | 11 |
| 59 | non-cbt | 11 |
| 60 | non-laba | 11 |
| 61 | two-needle | 11 |
| 62 | ydc | 11 |
| 63 | mdma-assisted | 10 |
| 64 | mentalisation-based | 10 |
| 65 | pressure-targeted | 10 |
| 66 | symptom-oriented | 10 |
| 67 | biomarker-guided | 9 |
| 68 | deltopectoral | 9 |
| 69 | extirpative | 9 |
| 70 | meaning-centered | 9 |
| 71 | medication-only | 9 |
| 72 | multizone | 9 |
| 73 | physio-psychological | 9 |
| 74 | pluridisciplinary | 9 |
| 75 | body-oriented | 8 |
| 76 | co-seasonal | 8 |
| 77 | cytapheresis | 8 |
| 78 | lasercomb | 8 |
| 79 | later-line | 8 |
| 80 | normoxemic | 8 |
| 81 | pet-assisted | 8 |
| 82 | uv-a1 | 8 |
| 83 | alcohol-dependence | 7 |
| 84 | alkali-heat | 7 |
| 85 | cinacalcet-centred | 7 |
| 86 | clarification-oriented | 7 |
| 87 | cryotherapeutic | 7 |
| 88 | non-icd | 7 |
| 89 | np-guided | 7 |
| 90 | one-stent | 7 |
| 91 | organ-preservation | 7 |
| 92 | post-cancer | 7 |
| 93 | procedure-based | 7 |
| 94 | risk-directed | 7 |
| 95 | self-health | 7 |
| 96 | shorter-duration | 7 |
| 97 | bladder-preserving | 6 |
| 98 | nrti-containing | 6 |
| 99 | superstimulatory | 6 |
| 100 | transference-focused | 6 |
| 101 | tvrc | 6 |
| 102 | adolescent-focused | 5 |
| 103 | antidepressant-benzodiazepine | 5 |
| 104 | bladder-sparing | 5 |
| 105 | chlorthalidone-based | 5 |
| 106 | ecologically-based | 5 |
| 107 | evidence-supported | 5 |
| 108 | high-intensification | 5 |
| 109 | lifestyle-medical | 5 |
| 110 | non-educational | 5 |
| 111 | nonscripted | 5 |
| 112 | peep/fio2 | 5 |
| 113 | srp+ndl | 5 |
| 114 | whole-liver | 5 |
| 115 | balloon-anchoring | 4 |
| 116 | cognitive-reminiscence | 4 |
| 117 | cs-free | 4 |
| 118 | dsme-based | 4 |
| 119 | ei-guided | 4 |
| 120 | fertiliser | 4 |
| 121 | individualist | 4 |
| 122 | less-intense | 4 |
| 123 | nicotine-dependence | 4 |
| 124 | non-anti-vegf | 4 |
| 125 | non-trauma-focused | 4 |
| 126 | reeg-guided | 4 |
| 127 | rti/std | 4 |
| 128 | sp-based | 4 |
| 129 | steam-heat | 4 |
| 130 | thermal-alkaline | 4 |
| 131 | thermoultrasound | 4 |
| 132 | acahw | 3 |
| 133 | alcohol-retention | 3 |
| 134 | aldoa | 3 |
| 135 | anti-hiv1 | 3 |
| 136 | anticellulite | 3 |
| 137 | bfm-based | 3 |
| 138 | brace-only | 3 |
| 139 | curative/life-prolonging | 3 |
| 140 | double-filtration | 3 |
| 141 | family/parental | 3 |
| 142 | highcpap | 3 |
| 143 | intravenous/intra-arterial | 3 |
| 144 | k-d | 3 |
| 145 | non-cetuximab | 3 |
| 146 | non-individualised | 3 |
| 147 | nutrient-based | 3 |
| 148 | pet-directed | 3 |
| 149 | pharmacotherapy-only | 3 |
| 150 | post-coronarography | 3 |
| 151 | rifamycin-combination | 3 |
| 152 | ro-317549 | 3 |
| 153 | sif+fa | 3 |
| 154 | surgical-orthodontic | 3 |
| 155 | temperature-lowering | 3 |
| 156 | temporising | 3 |
| 157 | thermoultrasonic | 3 |
| 158 | tramadol-ketamine | 3 |
| 159 | wolfsburg | 3 |
| 160 | 'combination | 2 |
| 161 | 3,541 | 2 |
| 162 | 60-wk | 2 |
| 163 | acupuncture/antipsychotic | 2 |
| 164 | anesthesic | 2 |
| 165 | angioplasty-first | 2 |
| 166 | aquathermal | 2 |
| 167 | as-needed/quarterly | 2 |
| 168 | behavioral-based | 2 |
| 169 | behavioral-cognitive | 2 |
| 170 | bnp/nt-probnp-guided | 2 |
| 171 | breast-maintaining | 2 |
| 172 | cbt-informed | 2 |
| 173 | chd-specific | 2 |
| 174 | chronic-condition | 2 |
| 175 | chronic-disease | 2 |
| 176 | cognitive/educational | 2 |
| 177 | consensus-derived | 2 |
| 178 | coping-oriented | 2 |
| 179 | correlation-based | 2 |
| 180 | ct-controlled | 2 |
| 181 | das-targeted | 2 |
| 182 | dual-illness | 2 |
| 183 | estradiol-progesterone | 2 |
| 184 | extrapedicular | 2 |
| 185 | hcg-based | 2 |
| 186 | hypnotherapeutic-behavioral | 2 |
| 187 | ibm-compatible | 2 |
| 188 | injection-compression | 2 |
| 189 | injection/compression | 2 |
| 190 | lapatinib-based | 2 |
| 191 | lay-based | 2 |
| 192 | low-cost/low-technology | 2 |
| 193 | low-intensification | 2 |
| 194 | medical/dietary | 2 |
| 195 | microecologic | 2 |
| 196 | minimal/no | 2 |
| 197 | monocausal | 2 |
| 198 | non-contingency | 2 |
| 199 | non-manualised | 2 |
| 200 | non-pap | 2 |
| 201 | peg/ribavirin | 2 |
| 202 | pharmacist/nurse | 2 |
| 203 | placebo/other | 2 |
| 204 | post-invasion | 2 |
| 205 | pre-bcao | 2 |
| 206 | red-laser | 2 |
| 207 | relaxation/stress | 2 |
| 208 | sex-group | 2 |
| 209 | single-allergen-specific | 2 |
| 210 | single-disease | 2 |
| 211 | single-illness | 2 |
| 212 | srl+csa+st | 2 |
| 213 | tace-plus-rfa | 2 |
| 214 | vendor-recommended | 2 |
| 215 | verum/sham | 2 |
| 216 | wba/active | 2 |
| 217 | 'aiding | 1 |
| 218 | 'imposed | 1 |
| 219 | 'medicines | 1 |
| 220 | *long-term | 1 |
| 221 | +parent | 1 |
| 222 | -oseltamivir | 1 |
| 223 | /active | 1 |
| 224 | 10,675 | 1 |
| 225 | 131-i | 1 |
| 226 | 30-mg/day | 1 |
| 227 | 4-callback | 1 |
| 228 | 4·5-h | 1 |
| 229 | 5-ht-selective | 1 |
| 230 | 5-question | 1 |
| 231 | 51-99 | 1 |
| 232 | 8-day+azithromycin | 1 |
| 233 | aa-modeled | 1 |
| 234 | acute-episode | 1 |
| 235 | adaptml | 1 |
| 236 | adoptivet | 1 |
| 237 | ala/mal-pdt | 1 |
| 238 | alfa-blocker | 1 |
| 239 | allergen‑specific | 1 |
| 240 | amplitude-guided | 1 |
| 241 | anodizing-heat | 1 |
| 242 | anti-interleukin-12/23 | 1 |
| 243 | antibiotic/antifungal | 1 |
| 244 | anticandidosic | 1 |
| 245 | antigen-nonspecific | 1 |
| 246 | avcfm | 1 |
| 247 | bap-first | 1 |
| 248 | bcg-alone | 1 |
| 249 | behavioural/psychosocial | 1 |
| 250 | bev-based | 1 |
| 251 | bicarbonate-centered | 1 |
| 252 | biofeedback-aided | 1 |
| 253 | biofeedback/stress | 1 |
| 254 | bp-specific | 1 |
| 255 | broadening/compression | 1 |
| 256 | bs/placebo | 1 |
| 257 | buphrenorphine | 1 |
| 258 | c-hab | 1 |
| 259 | cannabis-only | 1 |
| 260 | cannula-site | 1 |
| 261 | catheter-delivered | 1 |
| 262 | cd4-dependent | 1 |
| 263 | citalopram/placebo | 1 |
| 264 | claim-based | 1 |
| 265 | clinician-applied | 1 |
| 266 | colony-wide | 1 |
| 267 | communication-focused | 1 |
| 268 | coms-designated | 1 |
| 269 | conservatie | 1 |
| 270 | conservative-expectant | 1 |
| 271 | control/deferred | 1 |
| 272 | conventional-based | 1 |
| 273 | craving-suppressing | 1 |
| 274 | cryokinetic | 1 |
| 275 | currently-implemented | 1 |
| 276 | czp+mtx | 1 |
| 277 | d-lys-3-ghrp-6 | 1 |
| 278 | data-checking | 1 |
| 279 | daytime-only | 1 |
| 280 | decision-sharing | 1 |
| 281 | depression-care | 1 |
| 282 | didanosine/zidovudine-based | 1 |
| 283 | diet/weight | 1 |
| 284 | dietary/medical | 1 |
| 285 | dietetary | 1 |
| 286 | direction-based | 1 |
| 287 | disease-centric | 1 |
| 288 | disease-transforming | 1 |
| 289 | disulfiram-enhanced | 1 |
| 290 | dopamine-enhancement | 1 |
| 291 | endoscopic-based | 1 |
| 292 | enhancement/cognitive | 1 |
| 293 | erespal+atrovent | 1 |
| 294 | expective | 1 |
| 295 | extra-glycaemic | 1 |
| 296 | extrasaccular | 1 |
| 297 | fatigue-risk | 1 |
| 298 | favorite-last | 1 |
| 299 | feature-binding | 1 |
| 300 | fenofibrate-based | 1 |
| 301 | field-pea | 1 |
| 302 | first-endovascular | 1 |
| 303 | fluid-ingestion | 1 |
| 304 | food-composition | 1 |
| 305 | forty-four-week | 1 |
| 306 | four-modal | 1 |
| 307 | gdc-alone | 1 |
| 308 | gender-neutral | 1 |
| 309 | glibenclamide-containing | 1 |
| 310 | guideline-conform | 1 |
| 311 | guideline-implementation | 1 |
| 312 | guidelines-enforced | 1 |
| 313 | h1-antagonist | 1 |
| 314 | hatg-based | 1 |
| 315 | healthlight™ | 1 |
| 316 | histamine-based | 1 |
| 317 | human-delivered | 1 |
| 318 | human-targeted | 1 |
| 319 | humanistic-existential | 1 |
| 320 | ihm-based | 1 |
| 321 | imaging-enhancing | 1 |
| 322 | imipramine+clinical | 1 |
| 323 | individuality-concerned | 1 |
| 324 | inhibitor-blocker | 1 |
| 325 | ino/gc | 1 |
| 326 | institute-specific | 1 |
| 327 | interferon-beta-lb | 1 |
| 328 | internet-linked | 1 |
| 329 | intimacy-enhancing | 1 |
| 330 | intra-abomasal | 1 |
| 331 | invasive-medical | 1 |
| 332 | invasive-species | 1 |
| 333 | isoamylase | 1 |
| 334 | larvicide | 1 |
| 335 | ldl-c-based | 1 |
| 336 | legalise | 1 |
| 337 | less-presumptive | 1 |
| 338 | linagliptin-based | 1 |
| 339 | lipid-lower | 1 |
| 340 | lipid-regulation | 1 |
| 341 | lithotriptic | 1 |
| 342 | lockout-period | 1 |
| 343 | marital/couples | 1 |
| 344 | medication/therapeutic | 1 |
| 345 | mepivacaine-alone | 1 |
| 346 | met+cbt+contingency | 1 |
| 347 | met/cbt+contingency | 1 |
| 348 | metacycline | 1 |
| 349 | methylene-blue | 1 |
| 350 | metronidazole/tinidazole | 1 |
| 351 | microbiological/biochemical | 1 |
| 352 | microprocessed | 1 |
| 353 | minium | 1 |
| 354 | moderatesized | 1 |
| 355 | mono-drug | 1 |
| 356 | more-optimal | 1 |
| 357 | mortality.conventional | 1 |
| 358 | msc-based | 1 |
| 359 | multiple-surfaces | 1 |
| 360 | multiplevisit | 1 |
| 361 | murkin | 1 |
| 362 | mutliple | 1 |
| 363 | near-maintenance | 1 |
| 364 | next-pregnancy | 1 |
| 365 | no-lola | 1 |
| 366 | no/placebo | 1 |
| 367 | non-anti-egfr | 1 |
| 368 | non-antiviral | 1 |
| 369 | non-attempted | 1 |
| 370 | non-biofeedback | 1 |
| 371 | non-commencing | 1 |
| 372 | non-conformal | 1 |
| 373 | non-dacarbazine | 1 |
| 374 | non-epineurotomy | 1 |
| 375 | non-fertility-sparing | 1 |
| 376 | non-goal-directed | 1 |
| 377 | non-pharmacological/lifestyle | 1 |
| 378 | non-vk | 1 |
| 379 | nonantigen-specific | 1 |
| 380 | nonbiofeedback | 1 |
| 381 | noncapitated | 1 |
| 382 | nonmultidisciplinary | 1 |
| 383 | nonstatin-based | 1 |
| 384 | normothermia/iwbc | 1 |
| 385 | nrt/pharmacological | 1 |
| 386 | nuptiality | 1 |
| 387 | nutritional-hygienic | 1 |
| 388 | observation/nonsurgical | 1 |
| 389 | oligodendrogenic | 1 |
| 390 | open-abdomen | 1 |
| 391 | oral-based | 1 |
| 392 | oral/placebo | 1 |
| 393 | p9905 | 1 |
| 394 | patient-facing | 1 |
| 395 | patient-guided | 1 |
| 396 | peer-provided | 1 |
| 397 | pegifnα-2a-based | 1 |
| 398 | permit-guided | 1 |
| 399 | pernickety | 1 |
| 400 | personnel.the | 1 |
| 401 | pharmaco-genomic-guided | 1 |
| 402 | pharmacogenetic/pharmacogenomic | 1 |
| 403 | pharmocologic | 1 |
| 404 | physician-active | 1 |
| 405 | placebo+physical | 1 |
| 406 | placebo-neurofeedback | 1 |
| 407 | placebo/clopidogrel | 1 |
| 408 | placebo/conventional | 1 |
| 409 | placebo/expectant | 1 |
| 410 | post-adalimumab | 1 |
| 411 | post-capsaicin | 1 |
| 412 | post-idmi | 1 |
| 413 | post-iloprost/vehicle | 1 |
| 414 | post-nephrectomy | 1 |
| 415 | post-orthopedic | 1 |
| 416 | post-psychotherapeutic | 1 |
| 417 | post-salvage | 1 |
| 418 | post-seclusion | 1 |
| 419 | post-sirolimus | 1 |
| 420 | post-specific | 1 |
| 421 | post-swisswing | 1 |
| 422 | pparγ-agonist | 1 |
| 423 | practice/business | 1 |
| 424 | pre-/post-acupuncture | 1 |
| 425 | prn/quarterly | 1 |
| 426 | pro-alternative | 1 |
| 427 | proactive-nonrestrictive | 1 |
| 428 | proton-based | 1 |
| 429 | prvastatin | 1 |
| 430 | psychologic-behavioral | 1 |
| 431 | psychological-specific | 1 |
| 432 | psychotherapeutic/behavioral | 1 |
| 433 | psychotherapy-and | 1 |
| 434 | psychotherapy-based | 1 |
| 435 | psychotherapy/psychiatric | 1 |
| 436 | pth-suppressive | 1 |
| 437 | quetiapine-based | 1 |
| 438 | quitline-delivered | 1 |
| 439 | regadrin | 1 |
| 440 | reinduction-maintenance | 1 |
| 441 | research-informed | 1 |
| 442 | resort-based | 1 |
| 443 | resources/organizational | 1 |
| 444 | retro-sigmoid | 1 |
| 445 | reverse-sequence | 1 |
| 446 | rtms-treatment | 1 |
| 447 | screening/management | 1 |
| 448 | sems-based | 1 |
| 449 | specificity-driven | 1 |
| 450 | stimultaneous | 1 |
| 451 | study-guided | 1 |
| 452 | sublingual-specific | 1 |
| 453 | surgery+/-induction | 1 |
| 454 | surrogate-dependent | 1 |
| 455 | symptom-appropriate | 1 |
| 456 | tamoxifen/raloxifen | 1 |
| 457 | tdf/emtricitabine/efavirenz | 1 |
| 458 | technically-improved | 1 |
| 459 | tele-delivered | 1 |
| 460 | therapeutic/care | 1 |
| 461 | three-loading | 1 |
| 462 | time-to-other | 1 |
| 463 | tnfα/zvad | 1 |
| 464 | toxicity-adjusted | 1 |
| 465 | transtumoral | 1 |
| 466 | trauma/grief-focused | 1 |
| 467 | treatment.active | 1 |
| 468 | trials.case | 1 |
| 469 | tube-voltage | 1 |
| 470 | unpopulated | 1 |
| 471 | upon-waking | 1 |
| 472 | wait-list/delayed | 1 |
| 473 | western-accepted | 1 |
| 474 | wt1-based | 1 |
| 475 | zidovudine+lamivudine | 1 |
| 476 | ziovudine | 1 |
| 1 | 'aiding | 1 |
| 2 | 'combination | 2 |
| 3 | 'imposed | 1 |
| 4 | 'medicines | 1 |
| 5 | *long-term | 1 |
| 6 | +parent | 1 |
| 7 | -oseltamivir | 1 |
| 8 | /active | 1 |
| 9 | 10,675 | 1 |
| 10 | 131-i | 1 |
| 11 | 2-visit | 23 |
| 12 | 3,541 | 2 |
| 13 | 3-wall | 23 |
| 14 | 30-mg/day | 1 |
| 15 | 4-callback | 1 |
| 16 | 4·5-h | 1 |
| 17 | 5-ht-selective | 1 |
| 18 | 5-question | 1 |
| 19 | 51-99 | 1 |
| 20 | 60-wk | 2 |
| 21 | 8-day+azithromycin | 1 |
| 22 | aa-modeled | 1 |
| 23 | acahw | 3 |
| 24 | acupuncture/antipsychotic | 2 |
| 25 | acute-episode | 1 |
| 26 | adaptml | 1 |
| 27 | adolescent-focused | 5 |
| 28 | adoptivet | 1 |
| 29 | ala/mal-pdt | 1 |
| 30 | alcohol-dependence | 7 |
| 31 | alcohol-retention | 3 |
| 32 | aldoa | 3 |
| 33 | alfa-blocker | 1 |
| 34 | alkali-heat | 7 |
| 35 | allergen‑specific | 1 |
| 36 | amplitude-guided | 1 |
| 37 | anesthesic | 2 |
| 38 | angioplasty-first | 2 |
| 39 | anodizing-heat | 1 |
| 40 | anti-hiv1 | 3 |
| 41 | anti-interleukin-12/23 | 1 |
| 42 | antibiotic/antifungal | 1 |
| 43 | anticandidosic | 1 |
| 44 | anticellulite | 3 |
| 45 | antidepressant-benzodiazepine | 5 |
| 46 | antigen-nonspecific | 1 |
| 47 | aquathermal | 2 |
| 48 | as-needed/quarterly | 2 |
| 49 | atenolol-based | 76 |
| 50 | avcfm | 1 |
| 51 | balloon-anchoring | 4 |
| 52 | bap-first | 1 |
| 53 | bcg-alone | 1 |
| 54 | behavioral-based | 2 |
| 55 | behavioral-cognitive | 2 |
| 56 | behavioural/psychosocial | 1 |
| 57 | bev-based | 1 |
| 58 | bfm-based | 3 |
| 59 | bicarbonate-centered | 1 |
| 60 | biofeedback-aided | 1 |
| 61 | biofeedback/stress | 1 |
| 62 | biomarker-guided | 9 |
| 63 | bladder-preserving | 6 |
| 64 | bladder-sparing | 5 |
| 65 | bnp/nt-probnp-guided | 2 |
| 66 | body-oriented | 8 |
| 67 | bp-specific | 1 |
| 68 | brace-only | 3 |
| 69 | breast-conservation | 15 |
| 70 | breast-maintaining | 2 |
| 71 | broadening/compression | 1 |
| 72 | bs/placebo | 1 |
| 73 | buphrenorphine | 1 |
| 74 | c-hab | 1 |
| 75 | cannabis-only | 1 |
| 76 | cannula-site | 1 |
| 77 | catheter-delivered | 1 |
| 78 | cbt-informed | 2 |
| 79 | cbt/met | 11 |
| 80 | cd4-dependent | 1 |
| 81 | chd-specific | 2 |
| 82 | chlorthalidone-based | 5 |
| 83 | chronic-condition | 2 |
| 84 | chronic-disease | 2 |
| 85 | cinacalcet-centred | 7 |
| 86 | citalopram/placebo | 1 |
| 87 | claim-based | 1 |
| 88 | clarification-oriented | 7 |
| 89 | clinician-applied | 1 |
| 90 | co-seasonal | 8 |
| 91 | cognitive-behavioral | 1,258 |
| 92 | cognitive-behavioural | 415 |
| 93 | cognitive-reminiscence | 4 |
| 94 | cognitive/educational | 2 |
| 95 | colony-wide | 1 |
| 96 | combined-modality | 57 |
| 97 | communication-focused | 1 |
| 98 | coms-designated | 1 |
| 99 | consensus-derived | 2 |
| 100 | conservatie | 1 |
| 101 | conservative | 3,544 |
| 102 | conservative-expectant | 1 |
| 103 | contingency | 393 |
| 104 | control/deferred | 1 |
| 105 | conventional-based | 1 |
| 106 | coping-oriented | 2 |
| 107 | correlation-based | 2 |
| 108 | coseasonal | 13 |
| 109 | craving-suppressing | 1 |
| 110 | cryokinetic | 1 |
| 111 | cryotherapeutic | 7 |
| 112 | cs-free | 4 |
| 113 | ct-controlled | 2 |
| 114 | curative/life-prolonging | 3 |
| 115 | currently-implemented | 1 |
| 116 | cytapheresis | 8 |
| 117 | czp+mtx | 1 |
| 118 | d-lys-3-ghrp-6 | 1 |
| 119 | das-targeted | 2 |
| 120 | data-checking | 1 |
| 121 | daytime-only | 1 |
| 122 | decision-sharing | 1 |
| 123 | deltopectoral | 9 |
| 124 | depression-care | 1 |
| 125 | depression-specific | 29 |
| 126 | didanosine/zidovudine-based | 1 |
| 127 | diet/weight | 1 |
| 128 | dietary/medical | 1 |
| 129 | dietetary | 1 |
| 130 | direction-based | 1 |
| 131 | disease-centric | 1 |
| 132 | disease-transforming | 1 |
| 133 | disulfiram-enhanced | 1 |
| 134 | dopamine-enhancement | 1 |
| 135 | double-filtration | 3 |
| 136 | dsme-based | 4 |
| 137 | dual-combination | 36 |
| 138 | dual-illness | 2 |
| 139 | eclectic | 32 |
| 140 | ecologically-based | 5 |
| 141 | ei-guided | 4 |
| 142 | endodontic | 472 |
| 143 | endoscopic-based | 1 |
| 144 | endourologic | 29 |
| 145 | enhancement/cognitive | 1 |
| 146 | erespal+atrovent | 1 |
| 147 | estradiol-progesterone | 2 |
| 148 | evidence-supported | 5 |
| 149 | expectant | 692 |
| 150 | expective | 1 |
| 151 | extirpative | 9 |
| 152 | extra-glycaemic | 1 |
| 153 | extrapedicular | 2 |
| 154 | extrasaccular | 1 |
| 155 | family/parental | 3 |
| 156 | fatigue-risk | 1 |
| 157 | favorite-last | 1 |
| 158 | feature-binding | 1 |
| 159 | fenofibrate-based | 1 |
| 160 | fertiliser | 4 |
| 161 | field-pea | 1 |
| 162 | first-endovascular | 1 |
| 163 | fluid-ingestion | 1 |
| 164 | food-composition | 1 |
| 165 | forty-four-week | 1 |
| 166 | four-modal | 1 |
| 167 | gdc-alone | 1 |
| 168 | gender-neutral | 1 |
| 169 | glibenclamide-containing | 1 |
| 170 | guideline-conform | 1 |
| 171 | guideline-implementation | 1 |
| 172 | guidelines-based | 25 |
| 173 | guidelines-enforced | 1 |
| 174 | gut-directed | 25 |
| 175 | h1-antagonist | 1 |
| 176 | hatg-based | 1 |
| 177 | hcg-based | 2 |
| 178 | healthlight™ | 1 |
| 179 | high-intensification | 5 |
| 180 | highcpap | 3 |
| 181 | histamine-based | 1 |
| 182 | human-delivered | 1 |
| 183 | human-targeted | 1 |
| 184 | humanistic-existential | 1 |
| 185 | hypnotherapeutic-behavioral | 2 |
| 186 | ibm-compatible | 2 |
| 187 | ihm-based | 1 |
| 188 | imaging-enhancing | 1 |
| 189 | imipramine+clinical | 1 |
| 190 | individualist | 4 |
| 191 | individuality-concerned | 1 |
| 192 | inhibitor-blocker | 1 |
| 193 | injection-compression | 2 |
| 194 | injection/compression | 2 |
| 195 | ino/gc | 1 |
| 196 | institute-specific | 1 |
| 197 | insulin-providing | 11 |
| 198 | interferon-beta-lb | 1 |
| 199 | internet-linked | 1 |
| 200 | intimacy-enhancing | 1 |
| 201 | intra-abomasal | 1 |
| 202 | intravenous/intra-arterial | 3 |
| 203 | invasive-medical | 1 |
| 204 | invasive-species | 1 |
| 205 | isoamylase | 1 |
| 206 | k-d | 3 |
| 207 | lapatinib-based | 2 |
| 208 | larvicide | 1 |
| 209 | lasercomb | 8 |
| 210 | later-line | 8 |
| 211 | lay-based | 2 |
| 212 | ldl-c-based | 1 |
| 213 | legalise | 1 |
| 214 | less-intense | 4 |
| 215 | less-presumptive | 1 |
| 216 | lifestyle-medical | 5 |
| 217 | linagliptin-based | 1 |
| 218 | lipid-lower | 1 |
| 219 | lipid-regulation | 1 |
| 220 | lithotriptic | 1 |
| 221 | lockout-period | 1 |
| 222 | low-cost/low-technology | 2 |
| 223 | low-intensification | 2 |
| 224 | marital/couples | 1 |
| 225 | mcri | 13 |
| 226 | mdma-assisted | 10 |
| 227 | meaning-centered | 9 |
| 228 | medical/dietary | 2 |
| 229 | medicamentous | 25 |
| 230 | medication-assisted | 15 |
| 231 | medication-only | 9 |
| 232 | medication/therapeutic | 1 |
| 233 | mentalisation-based | 10 |
| 234 | mentalization-based | 20 |
| 235 | mepivacaine-alone | 1 |
| 236 | met+cbt+contingency | 1 |
| 237 | met/cbt+contingency | 1 |
| 238 | metacycline | 1 |
| 239 | methylene-blue | 1 |
| 240 | metronidazole/tinidazole | 1 |
| 241 | microbiological/biochemical | 1 |
| 242 | microecologic | 2 |
| 243 | microprocessed | 1 |
| 244 | minimal/no | 2 |
| 245 | minium | 1 |
| 246 | moderatesized | 1 |
| 247 | mono-drug | 1 |
| 248 | monocausal | 2 |
| 249 | more-optimal | 1 |
| 250 | mortality.conventional | 1 |
| 251 | msc-based | 1 |
| 252 | multi-modality | 32 |
| 253 | multimodality | 235 |
| 254 | multiple-surfaces | 1 |
| 255 | multiple-visit | 15 |
| 256 | multiplevisit | 1 |
| 257 | multizone | 9 |
| 258 | murkin | 1 |
| 259 | mutilating | 12 |
| 260 | mutliple | 1 |
| 261 | near-maintenance | 1 |
| 262 | next-pregnancy | 1 |
| 263 | next-step | 24 |
| 264 | nicotine-dependence | 4 |
| 265 | no-lola | 1 |
| 266 | no/placebo | 1 |
| 267 | non-anti-egfr | 1 |
| 268 | non-anti-vegf | 4 |
| 269 | non-antiviral | 1 |
| 270 | non-attempted | 1 |
| 271 | non-biofeedback | 1 |
| 272 | non-cbt | 11 |
| 273 | non-cetuximab | 3 |
| 274 | non-commencing | 1 |
| 275 | non-conformal | 1 |
| 276 | non-contingency | 2 |
| 277 | non-dacarbazine | 1 |
| 278 | non-educational | 5 |
| 279 | non-epineurotomy | 1 |
| 280 | non-extraction | 19 |
| 281 | non-fertility-sparing | 1 |
| 282 | non-goal-directed | 1 |
| 283 | non-icd | 7 |
| 284 | non-individualised | 3 |
| 285 | non-laba | 11 |
| 286 | non-manualised | 2 |
| 287 | non-operative | 170 |
| 288 | non-pap | 2 |
| 289 | non-pharmacological/lifestyle | 1 |
| 290 | non-surgical | 739 |
| 291 | non-trauma-focused | 4 |
| 292 | non-vk | 1 |
| 293 | nonantigen-specific | 1 |
| 294 | nonbeneficial | 29 |
| 295 | nonbiofeedback | 1 |
| 296 | noncapitated | 1 |
| 297 | nonmultidisciplinary | 1 |
| 298 | nonoperative | 522 |
| 299 | nonscripted | 5 |
| 300 | nonstatin-based | 1 |
| 301 | nonsurgical | 620 |
| 302 | normothermia/iwbc | 1 |
| 303 | normoxemic | 8 |
| 304 | np-guided | 7 |
| 305 | nrt/pharmacological | 1 |
| 306 | nrti-containing | 6 |
| 307 | nt-probnp-guided | 49 |
| 308 | nuptiality | 1 |
| 309 | nutrient-based | 3 |
| 310 | nutritional-hygienic | 1 |
| 311 | observation/nonsurgical | 1 |
| 312 | oligodendrogenic | 1 |
| 313 | one-stent | 7 |
| 314 | one-visit | 22 |
| 315 | open-abdomen | 1 |
| 316 | oral-based | 1 |
| 317 | oral/placebo | 1 |
| 318 | organ-preservation | 7 |
| 319 | orthograde | 17 |
| 320 | p9905 | 1 |
| 321 | patient-facing | 1 |
| 322 | patient-guided | 1 |
| 323 | peep/fio2 | 5 |
| 324 | peer-provided | 1 |
| 325 | peg/ribavirin | 2 |
| 326 | pegifnα-2a-based | 1 |
| 327 | permit-guided | 1 |
| 328 | pernickety | 1 |
| 329 | personnel.the | 1 |
| 330 | pet-assisted | 8 |
| 331 | pet-directed | 3 |
| 332 | pharmacist/nurse | 2 |
| 333 | pharmaco-genomic-guided | 1 |
| 334 | pharmacogenetic/pharmacogenomic | 1 |
| 335 | pharmacoinvasive | 32 |
| 336 | pharmacotherapy-only | 3 |
| 337 | pharmocologic | 1 |
| 338 | physician-active | 1 |
| 339 | physio-psychological | 9 |
| 340 | placebo+physical | 1 |
| 341 | placebo-neurofeedback | 1 |
| 342 | placebo/clopidogrel | 1 |
| 343 | placebo/conventional | 1 |
| 344 | placebo/expectant | 1 |
| 345 | placebo/no | 140 |
| 346 | placebo/other | 2 |
| 347 | pluridisciplinary | 9 |
| 348 | post-adalimumab | 1 |
| 349 | post-cancer | 7 |
| 350 | post-capsaicin | 1 |
| 351 | post-coronarography | 3 |
| 352 | post-idmi | 1 |
| 353 | post-iloprost/vehicle | 1 |
| 354 | post-invasion | 2 |
| 355 | post-nephrectomy | 1 |
| 356 | post-orthopedic | 1 |
| 357 | post-psychotherapeutic | 1 |
| 358 | post-salvage | 1 |
| 359 | post-seclusion | 1 |
| 360 | post-sirolimus | 1 |
| 361 | post-specific | 1 |
| 362 | post-swisswing | 1 |
| 363 | pparγ-agonist | 1 |
| 364 | practice/business | 1 |
| 365 | pre-/post-acupuncture | 1 |
| 366 | pre-bcao | 2 |
| 367 | present-centered | 19 |
| 368 | pressure-targeted | 10 |
| 369 | prn/quarterly | 1 |
| 370 | pro-alternative | 1 |
| 371 | proactive-nonrestrictive | 1 |
| 372 | procedure-based | 7 |
| 373 | proton-based | 1 |
| 374 | prvastatin | 1 |
| 375 | psychoanalytic | 97 |
| 376 | psychodynamic | 401 |
| 377 | psychologic-behavioral | 1 |
| 378 | psychological-specific | 1 |
| 379 | psychotherapeutic/behavioral | 1 |
| 380 | psychotherapy-and | 1 |
| 381 | psychotherapy-based | 1 |
| 382 | psychotherapy/psychiatric | 1 |
| 383 | pth-suppressive | 1 |
| 384 | quetiapine-based | 1 |
| 385 | quitline-delivered | 1 |
| 386 | rate-control | 66 |
| 387 | red-laser | 2 |
| 388 | reeg-guided | 4 |
| 389 | regadrin | 1 |
| 390 | reinduction-maintenance | 1 |
| 391 | relaxation/stress | 2 |
| 392 | research-informed | 1 |
| 393 | resort-based | 1 |
| 394 | resources/organizational | 1 |
| 395 | retro-sigmoid | 1 |
| 396 | reverse-sequence | 1 |
| 397 | rhythm-control | 54 |
| 398 | rifamycin-combination | 3 |
| 399 | risk-adapted | 68 |
| 400 | risk-directed | 7 |
| 401 | ro-317549 | 3 |
| 402 | rti/std | 4 |
| 403 | rtms-treatment | 1 |
| 404 | screening/management | 1 |
| 405 | self-health | 7 |
| 406 | sems-based | 1 |
| 407 | sex-group | 2 |
| 408 | shorter-duration | 7 |
| 409 | sif+fa | 3 |
| 410 | single-allergen-specific | 2 |
| 411 | single-disease | 2 |
| 412 | single-illness | 2 |
| 413 | single-modality | 23 |
| 414 | single-visit | 40 |
| 415 | solution-focused | 30 |
| 416 | sp-based | 4 |
| 417 | specificity-driven | 1 |
| 418 | srl+csa+st | 2 |
| 419 | srp+ndl | 5 |
| 420 | steam-heat | 4 |
| 421 | stimultaneous | 1 |
| 422 | study-guided | 1 |
| 423 | sublingual-specific | 1 |
| 424 | substance-abuse | 13 |
| 425 | superstimulatory | 6 |
| 426 | supportive-expressive | 24 |
| 427 | surgery+/-induction | 1 |
| 428 | surgical-orthodontic | 3 |
| 429 | surrogate-dependent | 1 |
| 430 | symptom-appropriate | 1 |
| 431 | symptom-oriented | 10 |
| 432 | syndromic | 285 |
| 433 | t2t | 16 |
| 434 | tace-plus-rfa | 2 |
| 435 | tamoxifen/raloxifen | 1 |
| 436 | tdf/emtricitabine/efavirenz | 1 |
| 437 | technically-improved | 1 |
| 438 | tele-delivered | 1 |
| 439 | temperature-lowering | 3 |
| 440 | temporising | 3 |
| 441 | therapeutic/care | 1 |
| 442 | therapist-administered | 12 |
| 443 | thermal-alkaline | 4 |
| 444 | thermoultrasonic | 3 |
| 445 | thermoultrasound | 4 |
| 446 | three-loading | 1 |
| 447 | time-to-other | 1 |
| 448 | tnfα/zvad | 1 |
| 449 | toxicity-adjusted | 1 |
| 450 | tramadol-ketamine | 3 |
| 451 | transference-focused | 6 |
| 452 | transtumoral | 1 |
| 453 | trauma/grief-focused | 1 |
| 454 | treatment.active | 1 |
| 455 | trials.case | 1 |
| 456 | trimodal | 15 |
| 457 | trimodality | 25 |
| 458 | tube-voltage | 1 |
| 459 | tvrc | 6 |
| 460 | two-needle | 11 |
| 461 | two-stent | 14 |
| 462 | two-visit | 21 |
| 463 | unpopulated | 1 |
| 464 | upon-waking | 1 |
| 465 | uv-a1 | 8 |
| 466 | vendor-recommended | 2 |
| 467 | verum/sham | 2 |
| 468 | wait-list/delayed | 1 |
| 469 | wba/active | 2 |
| 470 | western-accepted | 1 |
| 471 | whole-liver | 5 |
| 472 | wolfsburg | 3 |
| 473 | wt1-based | 1 |
| 474 | ydc | 11 |
| 475 | zidovudine+lamivudine | 1 |
| 476 | ziovudine | 1 |
| 1 | 3,541 | 2 |
| 2 | uv-a1 | 8 |
| 3 | anti-hiv1 | 3 |
| 4 | peep/fio2 | 5 |
| 5 | anti-interleukin-12/23 | 1 |
| 6 | p9905 | 1 |
| 7 | 10,675 | 1 |
| 8 | d-lys-3-ghrp-6 | 1 |
| 9 | ro-317549 | 3 |
| 10 | 51-99 | 1 |
| 11 | non-laba | 11 |
| 12 | field-pea | 1 |
| 13 | sif+fa | 3 |
| 14 | tace-plus-rfa | 2 |
| 15 | no-lola | 1 |
| 16 | aldoa | 3 |
| 17 | c-hab | 1 |
| 18 | non-cetuximab | 3 |
| 19 | post-adalimumab | 1 |
| 20 | interferon-beta-lb | 1 |
| 21 | lasercomb | 8 |
| 22 | normothermia/iwbc | 1 |
| 23 | ydc | 11 |
| 24 | ino/gc | 1 |
| 25 | post-orthopedic | 1 |
| 26 | chd-specific | 2 |
| 27 | institute-specific | 1 |
| 28 | psychological-specific | 1 |
| 29 | sublingual-specific | 1 |
| 30 | nonantigen-specific | 1 |
| 31 | single-allergen-specific | 2 |
| 32 | depression-specific | 29 |
| 33 | bp-specific | 1 |
| 34 | post-specific | 1 |
| 35 | antigen-nonspecific | 1 |
| 36 | allergen‑specific | 1 |
| 37 | microecologic | 2 |
| 38 | pharmocologic | 1 |
| 39 | endourologic | 29 |
| 40 | psychodynamic | 401 |
| 41 | extra-glycaemic | 1 |
| 42 | normoxemic | 8 |
| 43 | pharmacogenetic/pharmacogenomic | 1 |
| 44 | syndromic | 285 |
| 45 | oligodendrogenic | 1 |
| 46 | nutritional-hygienic | 1 |
| 47 | thermoultrasonic | 3 |
| 48 | psychotherapy/psychiatric | 1 |
| 49 | disease-centric | 1 |
| 50 | anesthesic | 2 |
| 51 | anticandidosic | 1 |
| 52 | eclectic | 32 |
| 53 | cryokinetic | 1 |
| 54 | endodontic | 472 |
| 55 | surgical-orthodontic | 3 |
| 56 | acupuncture/antipsychotic | 2 |
| 57 | lithotriptic | 1 |
| 58 | medication/therapeutic | 1 |
| 59 | post-psychotherapeutic | 1 |
| 60 | cryotherapeutic | 7 |
| 61 | psychoanalytic | 97 |
| 62 | tvrc | 6 |
| 63 | k-d | 3 |
| 64 | tnfα/zvad | 1 |
| 65 | non-icd | 7 |
| 66 | disulfiram-enhanced | 1 |
| 67 | guidelines-enforced | 1 |
| 68 | biofeedback-aided | 1 |
| 69 | pharmaco-genomic-guided | 1 |
| 70 | amplitude-guided | 1 |
| 71 | reeg-guided | 4 |
| 72 | ei-guided | 4 |
| 73 | np-guided | 7 |
| 74 | nt-probnp-guided | 49 |
| 75 | bnp/nt-probnp-guided | 2 |
| 76 | biomarker-guided | 9 |
| 77 | permit-guided | 1 |
| 78 | patient-guided | 1 |
| 79 | study-guided | 1 |
| 80 | peer-provided | 1 |
| 81 | vendor-recommended | 2 |
| 82 | clinician-applied | 1 |
| 83 | internet-linked | 1 |
| 84 | aa-modeled | 1 |
| 85 | ct-controlled | 2 |
| 86 | research-informed | 1 |
| 87 | cbt-informed | 2 |
| 88 | individuality-concerned | 1 |
| 89 | bicarbonate-centered | 1 |
| 90 | meaning-centered | 9 |
| 91 | present-centered | 19 |
| 92 | therapist-administered | 12 |
| 93 | tele-delivered | 1 |
| 94 | quitline-delivered | 1 |
| 95 | human-delivered | 1 |
| 96 | catheter-delivered | 1 |
| 97 | control/deferred | 1 |
| 98 | cinacalcet-centred | 7 |
| 99 | wt1-based | 1 |
| 100 | pegifnα-2a-based | 1 |
| 101 | lapatinib-based | 2 |
| 102 | ldl-c-based | 1 |
| 103 | endoscopic-based | 1 |
| 104 | msc-based | 1 |
| 105 | dsme-based | 4 |
| 106 | didanosine/zidovudine-based | 1 |
| 107 | histamine-based | 1 |
| 108 | quetiapine-based | 1 |
| 109 | chlorthalidone-based | 5 |
| 110 | procedure-based | 7 |
| 111 | fenofibrate-based | 1 |
| 112 | hcg-based | 2 |
| 113 | hatg-based | 1 |
| 114 | conventional-based | 1 |
| 115 | oral-based | 1 |
| 116 | behavioral-based | 2 |
| 117 | atenolol-based | 76 |
| 118 | bfm-based | 3 |
| 119 | ihm-based | 1 |
| 120 | claim-based | 1 |
| 121 | nonstatin-based | 1 |
| 122 | linagliptin-based | 1 |
| 123 | correlation-based | 2 |
| 124 | mentalisation-based | 10 |
| 125 | mentalization-based | 20 |
| 126 | direction-based | 1 |
| 127 | proton-based | 1 |
| 128 | sp-based | 4 |
| 129 | guidelines-based | 25 |
| 130 | sems-based | 1 |
| 131 | nutrient-based | 3 |
| 132 | resort-based | 1 |
| 133 | bev-based | 1 |
| 134 | lay-based | 2 |
| 135 | ecologically-based | 5 |
| 136 | psychotherapy-based | 1 |
| 137 | non-individualised | 3 |
| 138 | non-manualised | 2 |
| 139 | 'imposed | 1 |
| 140 | microprocessed | 1 |
| 141 | non-trauma-focused | 4 |
| 142 | transference-focused | 6 |
| 143 | trauma/grief-focused | 1 |
| 144 | communication-focused | 1 |
| 145 | solution-focused | 30 |
| 146 | adolescent-focused | 5 |
| 147 | unpopulated | 1 |
| 148 | coms-designated | 1 |
| 149 | noncapitated | 1 |
| 150 | risk-directed | 7 |
| 151 | non-goal-directed | 1 |
| 152 | pet-directed | 3 |
| 153 | gut-directed | 25 |
| 154 | pressure-targeted | 10 |
| 155 | human-targeted | 1 |
| 156 | das-targeted | 2 |
| 157 | coping-oriented | 2 |
| 158 | symptom-oriented | 10 |
| 159 | clarification-oriented | 7 |
| 160 | body-oriented | 8 |
| 161 | currently-implemented | 1 |
| 162 | risk-adapted | 68 |
| 163 | western-accepted | 1 |
| 164 | nonscripted | 5 |
| 165 | non-attempted | 1 |
| 166 | evidence-supported | 5 |
| 167 | mdma-assisted | 10 |
| 168 | medication-assisted | 15 |
| 169 | pet-assisted | 8 |
| 170 | toxicity-adjusted | 1 |
| 171 | consensus-derived | 2 |
| 172 | technically-improved | 1 |
| 173 | wait-list/delayed | 1 |
| 174 | moderatesized | 1 |
| 175 | retro-sigmoid | 1 |
| 176 | psychotherapy-and | 1 |
| 177 | thermoultrasound | 4 |
| 178 | lockout-period | 1 |
| 179 | rti/std | 4 |
| 180 | reinduction-maintenance | 1 |
| 181 | near-maintenance | 1 |
| 182 | cognitive-reminiscence | 4 |
| 183 | nicotine-dependence | 4 |
| 184 | alcohol-dependence | 7 |
| 185 | reverse-sequence | 1 |
| 186 | orthograde | 17 |
| 187 | larvicide | 1 |
| 188 | colony-wide | 1 |
| 189 | acute-episode | 1 |
| 190 | cs-free | 4 |
| 191 | tube-voltage | 1 |
| 192 | post-salvage | 1 |
| 193 | personnel.the | 1 |
| 194 | conservatie | 1 |
| 195 | ibm-compatible | 2 |
| 196 | post-iloprost/vehicle | 1 |
| 197 | two-needle | 11 |
| 198 | metronidazole/tinidazole | 1 |
| 199 | mutliple | 1 |
| 200 | non-pharmacological/lifestyle | 1 |
| 201 | zidovudine+lamivudine | 1 |
| 202 | ziovudine | 1 |
| 203 | buphrenorphine | 1 |
| 204 | later-line | 8 |
| 205 | thermal-alkaline | 4 |
| 206 | metacycline | 1 |
| 207 | tramadol-ketamine | 3 |
| 208 | antidepressant-benzodiazepine | 5 |
| 209 | non-dacarbazine | 1 |
| 210 | gdc-alone | 1 |
| 211 | mepivacaine-alone | 1 |
| 212 | bcg-alone | 1 |
| 213 | estradiol-progesterone | 2 |
| 214 | multizone | 9 |
| 215 | depression-care | 1 |
| 216 | therapeutic/care | 1 |
| 217 | pre-/post-acupuncture | 1 |
| 218 | trials.case | 1 |
| 219 | chronic-disease | 2 |
| 220 | single-disease | 2 |
| 221 | isoamylase | 1 |
| 222 | legalise | 1 |
| 223 | less-intense | 4 |
| 224 | pharmacist/nurse | 2 |
| 225 | substance-abuse | 13 |
| 226 | symptom-appropriate | 1 |
| 227 | anticellulite | 3 |
| 228 | cannula-site | 1 |
| 229 | methylene-blue | 1 |
| 230 | pharmacoinvasive | 32 |
| 231 | pth-suppressive | 1 |
| 232 | supportive-expressive | 24 |
| 233 | pro-alternative | 1 |
| 234 | extirpative | 9 |
| 235 | non-operative | 170 |
| 236 | nonoperative | 522 |
| 237 | conservative | 3,544 |
| 238 | physician-active | 1 |
| 239 | treatment.active | 1 |
| 240 | /active | 1 |
| 241 | wba/active | 2 |
| 242 | 5-ht-selective | 1 |
| 243 | expective | 1 |
| 244 | proactive-nonrestrictive | 1 |
| 245 | behavioral-cognitive | 2 |
| 246 | enhancement/cognitive | 1 |
| 247 | less-presumptive | 1 |
| 248 | non-anti-vegf | 4 |
| 249 | patient-facing | 1 |
| 250 | imaging-enhancing | 1 |
| 251 | intimacy-enhancing | 1 |
| 252 | non-commencing | 1 |
| 253 | three-loading | 1 |
| 254 | 'aiding | 1 |
| 255 | insulin-providing | 11 |
| 256 | feature-binding | 1 |
| 257 | curative/life-prolonging | 3 |
| 258 | upon-waking | 1 |
| 259 | data-checking | 1 |
| 260 | disease-transforming | 1 |
| 261 | breast-maintaining | 2 |
| 262 | glibenclamide-containing | 1 |
| 263 | nrti-containing | 6 |
| 264 | decision-sharing | 1 |
| 265 | bladder-sparing | 5 |
| 266 | non-fertility-sparing | 1 |
| 267 | temperature-lowering | 3 |
| 268 | balloon-anchoring | 4 |
| 269 | temporising | 3 |
| 270 | craving-suppressing | 1 |
| 271 | mutilating | 12 |
| 272 | bladder-preserving | 6 |
| 273 | post-swisswing | 1 |
| 274 | wolfsburg | 3 |
| 275 | mono-drug | 1 |
| 276 | 4·5-h | 1 |
| 277 | self-health | 7 |
| 278 | 131-i | 1 |
| 279 | post-idmi | 1 |
| 280 | mcri | 13 |
| 281 | non-biofeedback | 1 |
| 282 | nonbiofeedback | 1 |
| 283 | placebo-neurofeedback | 1 |
| 284 | 4-callback | 1 |
| 285 | forty-four-week | 1 |
| 286 | fatigue-risk | 1 |
| 287 | non-vk | 1 |
| 288 | 60-wk | 2 |
| 289 | lifestyle-medical | 5 |
| 290 | invasive-medical | 1 |
| 291 | dietary/medical | 1 |
| 292 | nrt/pharmacological | 1 |
| 293 | physio-psychological | 9 |
| 294 | non-surgical | 739 |
| 295 | nonsurgical | 620 |
| 296 | observation/nonsurgical | 1 |
| 297 | microbiological/biochemical | 1 |
| 298 | imipramine+clinical | 1 |
| 299 | placebo+physical | 1 |
| 300 | four-modal | 1 |
| 301 | trimodal | 15 |
| 302 | antibiotic/antifungal | 1 |
| 303 | nonbeneficial | 29 |
| 304 | behavioural/psychosocial | 1 |
| 305 | intravenous/intra-arterial | 3 |
| 306 | humanistic-existential | 1 |
| 307 | more-optimal | 1 |
| 308 | aquathermal | 2 |
| 309 | non-conformal | 1 |
| 310 | non-educational | 5 |
| 311 | cognitive/educational | 2 |
| 312 | resources/organizational | 1 |
| 313 | mortality.conventional | 1 |
| 314 | placebo/conventional | 1 |
| 315 | co-seasonal | 8 |
| 316 | coseasonal | 13 |
| 317 | non-antiviral | 1 |
| 318 | psychologic-behavioral | 1 |
| 319 | hypnotherapeutic-behavioral | 2 |
| 320 | cognitive-behavioral | 1,258 |
| 321 | psychotherapeutic/behavioral | 1 |
| 322 | transtumoral | 1 |
| 323 | deltopectoral | 9 |
| 324 | gender-neutral | 1 |
| 325 | cognitive-behavioural | 415 |
| 326 | intra-abomasal | 1 |
| 327 | monocausal | 2 |
| 328 | family/parental | 3 |
| 329 | srp+ndl | 5 |
| 330 | placebo/clopidogrel | 1 |
| 331 | 3-wall | 23 |
| 332 | adaptml | 1 |
| 333 | rate-control | 66 |
| 334 | rhythm-control | 54 |
| 335 | verum/sham | 2 |
| 336 | avcfm | 1 |
| 337 | *long-term | 1 |
| 338 | guideline-conform | 1 |
| 339 | minium | 1 |
| 340 | tamoxifen/raloxifen | 1 |
| 341 | open-abdomen | 1 |
| 342 | specificity-driven | 1 |
| 343 | post-capsaicin | 1 |
| 344 | 8-day+azithromycin | 1 |
| 345 | murkin | 1 |
| 346 | regadrin | 1 |
| 347 | peg/ribavirin | 2 |
| 348 | prvastatin | 1 |
| 349 | post-invasion | 2 |
| 350 | injection-compression | 2 |
| 351 | broadening/compression | 1 |
| 352 | injection/compression | 2 |
| 353 | post-seclusion | 1 |
| 354 | high-intensification | 5 |
| 355 | low-intensification | 2 |
| 356 | lipid-regulation | 1 |
| 357 | 'combination | 2 |
| 358 | dual-combination | 36 |
| 359 | rifamycin-combination | 3 |
| 360 | double-filtration | 3 |
| 361 | shorter-duration | 7 |
| 362 | guideline-implementation | 1 |
| 363 | organ-preservation | 7 |
| 364 | breast-conservation | 15 |
| 365 | non-extraction | 19 |
| 366 | surgery+/-induction | 1 |
| 367 | chronic-condition | 2 |
| 368 | food-composition | 1 |
| 369 | alcohol-retention | 3 |
| 370 | fluid-ingestion | 1 |
| 371 | 5-question | 1 |
| 372 | pre-bcao | 2 |
| 373 | oral/placebo | 1 |
| 374 | citalopram/placebo | 1 |
| 375 | no/placebo | 1 |
| 376 | bs/placebo | 1 |
| 377 | minimal/no | 2 |
| 378 | placebo/no | 140 |
| 379 | non-pap | 2 |
| 380 | highcpap | 3 |
| 381 | next-step | 24 |
| 382 | sex-group | 2 |
| 383 | extrasaccular | 1 |
| 384 | extrapedicular | 2 |
| 385 | first-endovascular | 1 |
| 386 | post-cancer | 7 |
| 387 | time-to-other | 1 |
| 388 | placebo/other | 2 |
| 389 | alfa-blocker | 1 |
| 390 | inhibitor-blocker | 1 |
| 391 | red-laser | 2 |
| 392 | fertiliser | 4 |
| 393 | whole-liver | 5 |
| 394 | lipid-lower | 1 |
| 395 | non-anti-egfr | 1 |
| 396 | -oseltamivir | 1 |
| 397 | multiple-surfaces | 1 |
| 398 | invasive-species | 1 |
| 399 | marital/couples | 1 |
| 400 | 'medicines | 1 |
| 401 | cytapheresis | 8 |
| 402 | practice/business | 1 |
| 403 | single-illness | 2 |
| 404 | dual-illness | 2 |
| 405 | biofeedback/stress | 1 |
| 406 | relaxation/stress | 2 |
| 407 | post-sirolimus | 1 |
| 408 | stimultaneous | 1 |
| 409 | medicamentous | 25 |
| 410 | t2t | 16 |
| 411 | anodizing-heat | 1 |
| 412 | alkali-heat | 7 |
| 413 | steam-heat | 4 |
| 414 | non-cbt | 11 |
| 415 | ala/mal-pdt | 1 |
| 416 | cbt/met | 11 |
| 417 | adoptivet | 1 |
| 418 | diet/weight | 1 |
| 419 | 2-visit | 23 |
| 420 | single-visit | 40 |
| 421 | multiple-visit | 15 |
| 422 | one-visit | 22 |
| 423 | two-visit | 21 |
| 424 | multiplevisit | 1 |
| 425 | expectant | 692 |
| 426 | conservative-expectant | 1 |
| 427 | placebo/expectant | 1 |
| 428 | cd4-dependent | 1 |
| 429 | surrogate-dependent | 1 |
| 430 | dopamine-enhancement | 1 |
| 431 | screening/management | 1 |
| 432 | rtms-treatment | 1 |
| 433 | +parent | 1 |
| 434 | one-stent | 7 |
| 435 | two-stent | 14 |
| 436 | erespal+atrovent | 1 |
| 437 | srl+csa+st | 2 |
| 438 | favorite-last | 1 |
| 439 | individualist | 4 |
| 440 | pparγ-agonist | 1 |
| 441 | h1-antagonist | 1 |
| 442 | bap-first | 1 |
| 443 | angioplasty-first | 2 |
| 444 | acahw | 3 |
| 445 | czp+mtx | 1 |
| 446 | 30-mg/day | 1 |
| 447 | next-pregnancy | 1 |
| 448 | contingency | 393 |
| 449 | met+cbt+contingency | 1 |
| 450 | met/cbt+contingency | 1 |
| 451 | non-contingency | 2 |
| 452 | low-cost/low-technology | 2 |
| 453 | post-coronarography | 3 |
| 454 | brace-only | 3 |
| 455 | daytime-only | 1 |
| 456 | medication-only | 9 |
| 457 | cannabis-only | 1 |
| 458 | pharmacotherapy-only | 3 |
| 459 | as-needed/quarterly | 2 |
| 460 | prn/quarterly | 1 |
| 461 | post-nephrectomy | 1 |
| 462 | non-epineurotomy | 1 |
| 463 | pluridisciplinary | 9 |
| 464 | nonmultidisciplinary | 1 |
| 465 | medical/dietary | 2 |
| 466 | dietetary | 1 |
| 467 | superstimulatory | 6 |
| 468 | pernickety | 1 |
| 469 | combined-modality | 57 |
| 470 | single-modality | 23 |
| 471 | multi-modality | 32 |
| 472 | trimodality | 25 |
| 473 | multimodality | 235 |
| 474 | nuptiality | 1 |
| 475 | tdf/emtricitabine/efavirenz | 1 |
| 476 | healthlight™ | 1 |